PetMed Express, Inc. Reports Earnings Results for the Third Quarter Ended December 31, 2020
January 19, 2021 at 08:00 am
Share
PetMed Express, Inc. announced earnings results for the third quarter ended December 31, 2020. For the third quarter, the company announced sales was USD 65.896 million compared to USD 59.915 million a year ago. Operating income was USD 9.293 million compared to USD 7.932 million a year ago. Net income was USD 7.611 million compared to USD 6.840 million a year ago. Basic earnings per share from continuing operations was USD 0.38 compared to USD 0.34 a year ago. For the nine months, sales was USD 237.536 million compared to USD 209.839 million a year ago. Operating income was USD 29.200 million compared to USD 22.464 million a year ago. Net income was USD 23.791 million compared to USD 18.848 million a year ago. Basic earnings per share from continuing operations was USD 1.19 compared to USD 0.94 a year ago. Diluted earnings per share from continuing operations was USD 1.18 compared to USD 0.94 a year ago.
PetMed Express, Inc., doing business as PetMeds, is a direct-to-consumer pet pharmacy. The Company is an online provider of prescription and non-prescription medications, food, supplements, and supplies and has veterinary and pet insurance service partnerships for dogs, cats, and horses. It markets and sells directly to consumers through their Websites, toll-free numbers, and employer benefit partnerships. Its product line contains over 15,000 SKUs of pet medications, health products, foods, and supplies. The Company offers various pet supplies, including beds, crates, stairs and other pet supplies. Its products include Prescription Medications (Rx), Non-Prescription Medications (OTC) and supplies, Pet Foods, Private Label and Holistic Wellness Services. Rx includes heartworm and flea and ticks preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
PETMED EXPRESS, INC. 
